AI Article Synopsis

  • Cholangiopathies are serious liver diseases, but existing human disease models are limited, prompting research into three-dimensional biliary organoids which may provide better insights.
  • By embedding biliary organoids into a specialized extracellular matrix, researchers created organoids that, when removed from this matrix, displayed a shift in organization and improved characteristics for studying liver function.
  • The study suggests that these new organoid models can enhance our understanding of bile transport, immune interactions, and the effects of the extracellular matrix on biliary health, potentially leading to better treatments for cholangiopathies.

Article Abstract

Background And Aims: Cholangiopathies are an important cause of morbidity and mortality. Their pathogenesis and treatment remain unclear in part because of the lack of disease models relevant to humans. Three-dimensional biliary organoids hold great promise; however, the inaccessibility of their apical pole and the presence of extracellular matrix (ECM) limits their application. We hypothesized that signals coming from the extracellular matrix regulate organoids' 3-dimensional architecture and could be manipulated to generate novel organotypic culture systems.

Approach And Results: Biliary organoids were generated from human livers and grown embedded into Culturex Basement Membrane Extract as spheroids around an internal lumen (EMB). When removed from the EMC, biliary organoids revert their polarity and expose the apical membrane on the outside (AOOs). Functional, immunohistochemical, and transmission electron microscope studies, along with bulk and single-cell transcriptomic, demonstrate that AOOs are less heterogeneous and show increased biliary differentiation and decreased expression of stem cell features. AOOs transport bile acids and have competent tight junctions. When cocultured with liver pathogenic bacteria (Enterococcus spp.), AOOs secrete a range of proinflammatory chemokines (ie, MCP1, IL8, CCL20, and IP-10). Transcriptomic analysis and treatment with a beta-1-integrin blocking antibody identified beta-1-integrin signaling as a sensor of the cell-extracellular matrix interaction and a determinant of organoid polarity.

Conclusions: This novel organoid model can be used to study bile transport, interactions with pathobionts, epithelial permeability, cross talk with other liver and immune cell types, and the effect of matrix changes on the biliary epithelium and obtain key insights into the pathobiology of cholangiopathies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503667PMC
http://dx.doi.org/10.1097/HC9.0000000000000094DOI Listing

Publication Analysis

Top Keywords

biliary organoids
12
extracellular matrix
8
biliary
6
cell-matrix interactions
4
interactions control
4
control biliary
4
biliary organoid
4
organoid polarity
4
polarity architecture
4
architecture differentiation
4

Similar Publications

Standard: Human gastric cancer organoids.

Cell Regen

December 2024

Guangzhou National Laboratory, Guangzhou, 510005, China.

Gastric cancer is one of the most common malignancies with poor prognosis. The use of organoids to simulate gastric cancer has rapidly developed over the past several years. Patient-derived gastric cancer organoids serve as in vitro models that closely mimics donor characteristics, offering new opportunities for both basic and applied research.

View Article and Find Full Text PDF

Cholangiocyte organoids for disease, cancer, and regenerative medicine.

Eur J Cell Biol

December 2024

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.

The biliary tract is a ductal network comprising the intrahepatic (IHBDs) and extrahepatic bile duct (EHBDs). Biliary duct disorders include cholangitis, neoplasms, and injury. However, the underlying mechanisms are not fully understood.

View Article and Find Full Text PDF

Understanding cell fate regulation in the liver is necessary to advance cell therapies for hepatic disease. Liver progenitor cells (LPC) contribute to tissue regeneration after severe hepatic injury yet signals instructing progenitor cell dynamics and fate are largely unknown. The Tissue Inhibitor of Metalloproteinases, TIMP1 and TIMP3 control the sheddases ADAM10 and ADAM17, key for NOTCH activation.

View Article and Find Full Text PDF

Drug-induced emesis is one of the major symptoms of gastrointestinal toxicity. Preclinical risk assessment of emesis has been challenging owing to the lack of suitable animal models or in vitro assay systems. One of the triggers of emesis is an excessive serotonin (5-HT) release from enterochromaffin (EC) cells in the intestinal tract, which activates the vomiting center in the brain stem and elicits the vomiting reflex.

View Article and Find Full Text PDF
Article Synopsis
  • The review investigates new regenerative medicine techniques to treat cholestatic liver fibrosis, which results from diseases like primary biliary cholangitis, leading to severe liver damage.
  • Understanding how these diseases progress is essential since current treatments mainly address underlying causes rather than the fibrosis itself.
  • The article highlights promising regenerative therapies like mesenchymal stem cell therapy and organoid technology, aiming to target fibrosis directly for better outcomes and potentially curative strategies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!